First Time Loading...

Aslan Pharmaceuticals Ltd
NASDAQ:ASLN

Watchlist Manager
Aslan Pharmaceuticals Ltd Logo
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Watchlist
Price: 0.4244 USD -5.08% Market Closed
Updated: May 7, 2024

Aslan Pharmaceuticals Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aslan Pharmaceuticals Ltd
Operating Income Peer Comparison

Comparables:

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Operating Income
-$12.8m
CAGR 3-Years
23%
CAGR 5-Years
12%
CAGR 10-Years
N/A

See Also

What is Aslan Pharmaceuticals Ltd's Operating Income?
Operating Income
-12.8m USD

Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Operating Income amounts to -12.8m USD.

What is Aslan Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
12%

Over the last year, the Operating Income growth was 55%. The average annual Operating Income growth rates for Aslan Pharmaceuticals Ltd have been 23% over the past three years , 12% over the past five years .